Vysioneer
About Vysioneer
Vysioneer is an oncology AI company dedicated to transforming cancer care through the application of machine learning. Their core mission is to expedite the delivery of effective therapies to cancer patients by enhancing drug efficacy with lesion-level precision. The company leverages its proprietary, FDA-cleared, cloud-based AI platform to augment clinicians’ productivity and facilitate precision medicine, ultimately aiming for improved patient outcomes.
For physicians, Vysioneer’s technology offers practical solutions, such as their featured product, VBrain. This is a pioneering tumor auto-contouring system designed to optimize brain tumor radiosurgery by identifying common brain tumors like metastasis, meningioma, and acoustic neuroma. This capability significantly accelerates the radiosurgery treatment planning workflow, providing a “second set of eyes and hands” to assist in analyzing and segmenting medical scans. Beyond brain tumors, their platform supports automatic image analysis for various clinical findings across different imaging modalities.
Vysioneer’s AI solutions are actively utilized in both clinical practice and pharmaceutical clinical development, with collaborations including Pfizer and the Stanford Cancer Institute. The company aims to establish a new standard for evaluating drug efficacy, providing data with significantly higher granularity (10 to 50 times more) than current methods. This enhanced data can enable pharmaceutical companies to make earlier and more confident decisions in clinical trials, thereby accelerating the development and approval of new cancer treatments.
Focus Areas
Business Intelligence
| Key Investors | Chaac Ventures, JLABS |
| Partnerships | Pfizer, MC Medical, Stanford Cancer Institute, GE Healthcare, Mary Bird Perkins Cancer Center, NVIDIA |
| Technology | Cloud-based AI platform, Deep Learning Technology, Neural Network-based AI solution, Vendor-neutral, GPU-accelerated compute ecosystem |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Vysioneer's solutions, particularly VBrain, offer significant advantages by acting as a 'second set of eyes and hands' to enhance accuracy and efficiency in radiation oncology. You can expect a dramatic reduction in manual contouring time (up to 30.8% decrease in treatment planning time), allowing more focus on patient care. The AI demonstrates higher sensitivity (12.2%) for lesion detection, even identifying lesions that might be missed by the human eye, and improves contouring accuracy for clinicians of all skill levels. This leads to more precise treatment planning and potentially better patient outcomes. For those involved in clinical trials, Vysioneer's AI provides unparalleled granularity in drug efficacy assessment, enabling earlier and more confident decisions in drug development and exploring novel endpoints beyond traditional RECIST criteria.
Vysioneer's VBrain is a cloud-based, vendor-neutral solution designed for seamless integration into existing clinical workflows, supporting data routing to and from DICOM nodes within a hospital network. They have established collaborations with major healthcare technology providers like GE Healthcare to make their solutions available on GE equipment, further facilitating integration into diverse clinical environments. The company also works with NVIDIA, leveraging GPUs for accelerated development and deployment, and plans to make AI solutions available on NVIDIA NGC for streamlined software delivery.
Reviews & Opinions
Videos
News, demos, and interviews about Vysioneer.
Videos load interactively. If none appear, search YouTube for Vysioneer →
Press & Coverage
Frequently Asked Questions
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]
Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]
Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]